Canada Pension Plan Investment Board Clovis Oncology, Inc. Transaction History

Canada Pension Plan Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.82 - $7.72 $29,402 - $47,092	-6,100 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $34,709 - $59,109	6,100 New	6,100 $41,000
Q1 2018 May 14, 2018	SELL	$50.12 - $67.72 $1.29 Million - $1.74 Million	-25,700 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $98,073 - $143,786	-1,700 Reduced 6.2%	25,700 $1.75 Million
Q3 2017 Oct 30, 2017	SELL	$67.17 - $84.81 $1.27 Million - $1.6 Million	-18,900 Reduced 40.82%	27,400 $2.26 Million
Q2 2017 Jan 31, 2018	SELL	N/A	-4,000 Reduced 7.95%	46,300 $4.34 Million
Q1 2017 Jan 31, 2018	BUY	N/A	50,300	50,300 $3.2 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.